ArticleJournal of neuroengineering and rehabilitation2025
Effect of focal muscle vibration on sEMG activity during repeated elbow movements in healthy adults.
Article in Journal of neuroengineering and rehabilitation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundFocal muscle vibration (FMV) is a non-invasive intervention that can modulate neuromuscular excitability, traditionally assessed with electrostimulation-evoked responses like F-waves or H-reflexes, which can be uncomfortable and impractical for many populations. Although the effects of FMV on targeted muscles have been well characterized, its impact on antagonist muscles, particularly during recovery after stimulation, remains poorly understood. Surface electromyography (sEMG) offers a non-invasive and clinically accessible method to assess these short-term changes and guide FMV-based interventions.
methods30 healthy adults participated in a within-subjects crossover design with two sessions (control and FMV) separated by at least 24 h. Both sessions began with a baseline recording of triceps sEMG during repeated elbow flexion-extension movements to assess initial muscle activation. In the FMV session, focal vibration (120 Hz, 1.2 mm amplitude) was applied to the biceps brachii (agonist) for 5 min immediately after baseline, whereas in the control session, participants rested quietly for the same duration. In both sessions, triceps brachii (antagonist) activity was recorded using sEMG every 5 min over a 30-minute follow-up period, resulting in 7 trials. Root mean square (RMS) values were computed for each trial and expressed as post-baseline ratios. Intragroup effects were analyzed using linear mixed-effects models to account for repeated measures. Intergroup differences (FMV vs. control) were evaluated using paired t-tests or Wilcoxon signed-rank tests when normality was violated. All resulting p-values were adjusted using the Benjamini-Hochberg procedure to control the false discovery rate.
resultsFMV induced a significant and sustained reduction in triceps RMS ratios, lasting up to 20 min post-intervention (p < 0.05). The control session showed no significant changes. Intergroup comparisons revealed lower RMS ratios in the FMV session at several follow-up time points (p < 0.05), which remained significant after the p-value adjustment.
conclusionsThe findings support the hypothesis that FMV applied to the agonist muscle can transiently attenuate antagonist (triceps) muscle activity. sEMG proved to be a suitable and accessible method for detecting vibration-induced changes in muscle activation. This neuromodulatory effect may represent a promising tool for future rehabilitation or motor training strategies aimed at enhancing neuromuscular control and functional recovery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.